Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valérie Dyevre
No Evidence for Changes in Skeletal Muscle Mass or Weight During First-Line Chemotherapy for Metastatic Colorectal Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Capecitabine and Irinotecan as First- Line Chemotherapy for Patients With Metastatic Colorectal Cancer
Journal of IMAB - Annual Proceeding (Scientific Papers)
Dentistry
Occurrence and Characteristics of Hospitalizations During First-Line Chemotherapy Among Individuals With Metastatic Colorectal Cancer
Cancer Management and Research
Oncology
Cetuximab in First Line Treatment of Metastatic Colorectal Cancer
Farmeconomia. Health economics and therapeutic pathways
Skeletal Muscle Mass Reduction Velocity as a Simple Prognostic Indicator for Patients With Metastatic Urothelial Carcinoma Receiving Second-Line Chemotherapy
Asian Pacific Journal of Cancer Prevention
First-Line Therapy for Metastatic Colorectal Cancer: Current Perspectives and Future Directions
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Efficacy of Continued Cetuximab for Unresectable Metastatic Colorectal Cancer After Disease Progression During First-Line Cetuximab-Based Chemotherapy: A Retrospective Cohort Study
Oncotarget
Oncology
Reply: Oxaliplatin- Or Irinotecan-Based Chemotherapy for Metastatic Colorectal Cancer in the Elderly
British Journal of Cancer
Cancer Research
Oncology
First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Third- Or Later-Line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice
Clinical Colorectal Cancer
Oncology
Gastroenterology
